造血干细胞移植治疗重型再生障碍性贫血患者21例
摘要
重型再生障碍性贫血（SAA）是一种严重的骨髓造血功能衰竭性疾病，病程短、进展快、死亡率高。SAA的主要治疗方案有免疫抑制治疗（IST）和造血干细胞移植（HSCT）。本文回顾性分析了HSCT治疗21例SAA患者的疗效，现报道如下。
出处
《中华器官移植杂志》
CAS
CSCD
2016年第5期309-310,共2页
Chinese Journal of Organ Transplantation
参考文献8
-
1LiangJ, Yagasaki H, Kamachi Y, et al. Mutations in telomerase catalytic protein in Japanese children with aplastic anemia[J]. Haematologica, 2006, 91(5):656-658.
-
2Scheinberg P. Aplastic anemia: therapeutic updates in and transplantation[J]. Hematology Am Soc Hematol Educ Program, 2012, 2012: 292-300. DOI: 10. 1182/asheducation- 2012. 1. 292.
-
3Passweg JR, Marsh JC. Aplastic anemia., first-line treatment by immuno-suppression and sibling marrow transplantation [J]. Hematology Am Soc Hematol Educ Program, 2010, 2010:36-42. DOI: 10. 1182/asheducation-2010. 1.36.
-
4Kosaka Y, Yagasaki H, Sano K, et al. Prospective multicenter trial com-paring repeated therapy with stem-cell transplantation from an alternative donor as second-line treatment for children with severe and very severe aplastic anemia[J]. Blood, 2008, 111 (3): 1054- 1059.
-
5Gurion R, Gafter-Gvili A, Paul M, et al. Hematopoietic growth factors in aplastic anemia patients treated with immunosuppressive therapy systema-tic review and meta- analysis[J]. Haematologica, 2009, 94(5) :712-719. DOI: 10. 3324/haetfiatol. 2008. 002170.
-
6Bacigalupo A, Socie" G, Lanino E, et al. Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party[J]. Haemato- logica, 2010, 95 (6): 976-982. DOI.. 10. 3324/ haematol. 2009. 018267.
-
7Viollier R, Passweg J, Gregor M, et al. Quality-adjusted survival analysis shows differences in outcome after or bone marrow transplantation in aplastic anemia[J]. Ann Hematol, 2005, 84(1):47-55.
-
8Yagasaki H, Takahashi Y, Hama A, et al. Comparison of matched-sibling donor BMT and unrelated donor BMT in children and adolescent with acquired severe aplastic anemia [J]. Bone Marrow Transplant, 2010, 45 (10): 1508-1513.
-
1刘媛,秦晶,彭昳.护理干预在重型再生障碍性贫血患者预防感染中的应用[J].吉林医学,2010,31(34):6363-6364. 被引量：5
-
2邵宗鸿.重视重型再生障碍性贫血患者感染的预防与治疗[J].中华血液学杂志,2012,33(3):161-162. 被引量：13
-
3张兴霞,刘立民,赵广圣,司叶俊,林国强,马爱迪,孙雨梅,张彦明,何广胜,吴德沛.猪抗人淋巴细胞球蛋白联合环孢素治疗重型再生障碍性贫血患者22例[J].中华血液学杂志,2014,35(5):451-453. 被引量：10
-
4刘威.预见性护理在重型再生障碍性贫血患者中的应用[J].吉林医学,2017,38(2):397-398. 被引量：3
-
5凌兰兰,陈月,于亮.造血干细胞移植治疗银屑病研究进展[J].中国综合临床,2016,32(5):475-478. 被引量：2
-
6卢静,吴德沛,胡绍燕,金松,王秀丽,苗瞄,陈佳,韩悦,唐晓文,仇惠英,孙爱宁,金正明,傅铮铮,马骁,陈峰.不同方式异基因造血干细胞移植治疗63例重型再生障碍性贫血患者的预后比较[J].中华血液学杂志,2015,36(8):633-636. 被引量：15
-
7刘世哲,陈香丽,付莹.重型再生障碍性贫血患者中健康教育的应用探析[J].中外女性健康研究,2015,0(11):110-111. 被引量：1
-
8蒋祖军,肖浩文,庞妍,肖扬.造血干细胞移植后带状疱疹发生率的分析[J].中国感染与化疗杂志,2012,12(2):88-91.
-
9胡令彦,周永明,陈英坤,胡明辉.非重型再生障碍性贫血患者Th17/Treg比例及相关细胞因子白细胞介素-6、-17和转化生长因子β1水平的临床意义[J].临床内科杂志,2013,30(9):636-638. 被引量：4
-
10白玉盛,李晓征.重型再生障碍性贫血患者中医证型分布及其与疗效的相关性[J].中医杂志,2011,52(7):562-563.
